cellspect
Latest round
- Series A
Last raised
- Apr 2016
Total raised
- $1.3M
Investors
- 2
About cellspect
, Ltd., Ltd. is a company focused on developing diagnostic technologies and research tools. Founded in 2014 in Morioka-shi, Japan, it has completed 8 deals to date., Ltd. specializes in a diverse array of diagnostic products and research tools aimed at enhancing healthcare and scientific research. The company's primary offerings include the Quonpass® COVID-19 Antigen Testing Kits, available in both professional and home-use formats, as well as the Compass View MD3 clinical testing services tailored for healthcare institutions. Their research products, such as Metal Assays, Micro Assays, and Redox Assays, serve laboratories and research facilities, addressing critical needs in microbial analysis and antimicrobial resistance studies. These products are designed for a broad customer base, including hospitals, research institutions, and public health organizations, particularly within Japan and select international markets., Ltd. generates revenue through a combination of direct-to-consumer sales and business-to-business transactions. The primary revenue streams stem from the sale of their diagnostic kits and clinical testing services, with potential partnerships established with healthcare providers and research institutions. The flagship product, Quonpass® COVID-19 Antigen Testing Kit, represents a significant portion of their revenue, catering to both individual consumers and healthcare facilities. Typical transactions involve direct purchases by clients, who may place orders for bulk quantities of diagnostic kits or subscribe to ongoing clinical testing services. The company is focused on introducing new diagnostic products in the near future and aims to expand its market presence in additional international regions by the end of 2025.
Who invested in cellspect
2 investors across 1 round
See all investors in cellspect
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 1, 2016
Amount
$1.3M
Investors
Questions about cellspect
Who invested in cellspect?
cellspect has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has cellspect raised?
cellspect has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did cellspect last raise money?
cellspect's most recent round on record is a Series A, in Apr 2016.
What does cellspect do?
cellspect is a pharmaceuticals company.
Where is cellspect headquartered?
cellspect is headquartered in Morioka-shi, Japan.
Which VCs invest in companies like cellspect?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at cellspect's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like cellspect? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.